Correlation Between Intellia Therapeutics and Pacific Biosciences
Can any of the company-specific risk be diversified away by investing in both Intellia Therapeutics and Pacific Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intellia Therapeutics and Pacific Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intellia Therapeutics and Pacific Biosciences of, you can compare the effects of market volatilities on Intellia Therapeutics and Pacific Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intellia Therapeutics with a short position of Pacific Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intellia Therapeutics and Pacific Biosciences.
Diversification Opportunities for Intellia Therapeutics and Pacific Biosciences
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Intellia and Pacific is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and Pacific Biosciences of in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacific Biosciences and Intellia Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intellia Therapeutics are associated (or correlated) with Pacific Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacific Biosciences has no effect on the direction of Intellia Therapeutics i.e., Intellia Therapeutics and Pacific Biosciences go up and down completely randomly.
Pair Corralation between Intellia Therapeutics and Pacific Biosciences
Given the investment horizon of 90 days Intellia Therapeutics is expected to generate 0.63 times more return on investment than Pacific Biosciences. However, Intellia Therapeutics is 1.58 times less risky than Pacific Biosciences. It trades about 0.06 of its potential returns per unit of risk. Pacific Biosciences of is currently generating about -0.18 per unit of risk. If you would invest 1,514 in Intellia Therapeutics on September 3, 2024 and sell it today you would earn a total of 48.00 from holding Intellia Therapeutics or generate 3.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intellia Therapeutics vs. Pacific Biosciences of
Performance |
| Timeline |
| Intellia Therapeutics |
| Pacific Biosciences |
Intellia Therapeutics and Pacific Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intellia Therapeutics and Pacific Biosciences
The main advantage of trading using opposite Intellia Therapeutics and Pacific Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intellia Therapeutics position performs unexpectedly, Pacific Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacific Biosciences will offset losses from the drop in Pacific Biosciences' long position.| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
| Pacific Biosciences vs. Twist Bioscience Corp | Pacific Biosciences vs. Intellia Therapeutics | Pacific Biosciences vs. Crispr Therapeutics AG | Pacific Biosciences vs. Editas Medicine |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |